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Foreign DNA activates the innate immune response through Toll-like receptor 9 (TLR9). In this issue of
Immunity, Park et al. (2011) present evidence that granulin is a cofactor for TLR9 activation, delivering
CpG-oligodeoxynucleotides to TLR9 in endolysosomes.A far cry from the simple saccules drawn
in textbooks, the endolysosomes of
phagocytic cells are complex organelles
within which many biochemical transfor-
mations occur, some of them essential
for normal immune function. Only recently
has the role of the endolysosome as a
sensory organelle been appreciated, and
much work still needs to be done to fully
understand its operation as such.
The DNA sensor Toll-like receptor 9
(TLR9) traffics from the endoplasmic retic-
ulum(ER) toendolysosomalcompartments,
where it encounters ligand and activates
innate immune responses (BlasiusandBeu-
tler, 2010). UNC93B, a 12 transmembrane
spanning protein, associates with TLR9
and is required for the transport of TLR9
from the ER to endolysosomes. ER chaper-
ones Gp96 and PRAT4A also play roles in
TLR9 trafficking. Once in endolysosomes,
TLR9 is proteolytically cleaved within its
ectodomain to generate a signaling-com-
petent receptor capable of recruiting
MyD88and initiatingdownstreamsignaling.
Multiple proteases have been implicated in
TLR9 cleavage, an event that requires
proper endolysosomal acidification.
Different proteins are needed to set up
the endolysosomal DNA sensing system
in different cell types. In addition to the
aforementioned proteins, in plasmacytoid
dendritic cells, lysosomal sorting proteins
of the AP-3, BLOC-1, and BLOC-2
complexes and the 12 transmembrane
spanning peptide-proton symporter
channel Slc15a4 are additionally required
to permit TLR9 signaling, leading both to
inflammatory cytokine production and to
the abundant type I interferon production
for which these cells are specialized (Bla-
sius et al., 2010). TLR7 signaling depends
on the same set of proteins and the same
modified endolysosomal compartment.To this collection of molecules and
events essential for TLR9 signaling, Park
et al. (2011) contribute information con-
cerning the initiation of signaling by
TLR9. They present evidence that the
cysteine-rich protein granulin functions
to deliver CpG oligodeoxynucleotides
(CpG-ODN) to TLR9 in endolysosomal
compartments. Granulin interacts with
both TLR9 and CpG-ODN in pull-down
assays from RAW264.7 macrophages. It
is constitutively secreted by wild-type
bone marrow-derived macrophages
(BMDM) and dendritic cells (BMDC), and
its presence in the extracellular milieu is
required for proinflammatory cytokine
production induced specifically by CpG-
ODN, but not poly(I:C) or imiquimod
(TLR3 and TLR7 ligands, respectively).
Ironically, the importance of granulin to
TLR9 activationmay have gone unnoticed
(and in fact granulin was proposed to be
anti-inflammatory) (Yin et al., 2010)
because of its property as a secreted
protein, which causes its presence in
serum. As a result, granulin-deficient
BMDM cultured in serum-containing
media respond normally to stimulation
with CpG-ODN. When cultured in serum-
free media, granulin-deficient BMDM
have a greatly reduced response to
CpG-ODN, a defect that is rescued by
addition of purified granulin. Thus, the
role of granulin in promoting TLR9 activa-
tion is cell extrinsic.
The idea that granulin serves to deliver
CpG-ODN to TLR9 is supported by the
finding that fluorescently labeled CpG-
ODN internalized by RAW264.7 macro-
phages colocalized with fluorescently
tagged granulin expressed heterolo-
gously. The association of biotin-CpG
with the cleaved form of TLR9 in pull-
down assays from granulin-deficient cellsImmunitywas greatly enhanced by the addition of
purified granulin, suggesting that granulin
is a cofactor for CpG-mediated TLR9
activation. More importantly, 75% fewer
granulin-deficient BMDM (in serum-free
culture) internalized CpG-ODN compared
to wild-type BMDM; supplying exoge-
nous granulin to the cells restored their
ability to acquire CpG-ODN. Paradoxi-
cally, this internalized CpG-ODN failed to
colocalize with a marker of endolysoso-
mal compartments. Although not tested
in this report, granulin itself probably
enters endolysosomes to interact tran-
siently with TLR9 before being rapidly
degraded by lysosomal proteases. In
support of this hypothesis, copurification
of granulin and TLR9 from RAW264.7
macrophages was found to require treat-
ment with z-FA-fmk, a cysteine protease
inhibitor specific for cathepsins.
What is granulin? Granulin was initially
identified during experiments to purify
peptides of the innate immune response
from extracts of human leukocytes,
including granulocytes; it was indepen-
dently found as a modulator of cell pro-
liferation from kidney epithelial cells
(Bateman and Bennett, 2009). Granulin is
now known to have widespread effects
throughout the body, participating in
embryogenesis, wound repair, oncogen-
esis, inflammation, and the maintenance
of neuronal survival. Heterozygous muta-
tions in the human granulin gene, GRN,
cause tau-negative ubiquitin-positive
frontotemporal lobar degeneration
(FTLDU) because of haploinsufficiency
(Bateman and Bennett, 2009). As a result
of neuronal death in the frontotemporal
cortex, FTLDU patients experience pro-
gressive changes in behavior, personality,
and cognitive and language ability, some-
times accompanied by Parkinsonism. The34, April 22, 2011 ª2011 Elsevier Inc. 453
Figure 1. Hypothetical Model for Granulin Function in TLR9 Signaling in Macrophages
Progranulin is constitutively secreted into the extracellular space, where it is cleaved by elastase. Whether
this cleavage is signal dependent is unknown. When present, CpG-ODN are bound by progranulin and/or
granulin; the mode of interaction is unknown. The lysosomal sorting protein sortilin may act as the granulin
receptor (as it does in neurons), bringing progranulin or granulin and bound CpG-ODN into the cell to
endolysosomal compartments containing TLR9. Progranulin or granulin facilitates the interaction of
CpG-ODN with TLR9, permitting the efficient initiation of MyD88-dependent signaling leading to proin-
flammatory cytokine production. Once in endolysosomes, CpG-bound and free progranulin or granulin
are rapidly degraded, possibly by cathepsins, and sortilin may be recycled to the cell surface.
Figure prepared by D. La Vine.
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mutations in GRN cause neurodegenera-
tion remains to be fully elucidated, a
particularly challenging task because of
the lack of a Grn-deficient rodent model
that phenocopies the human disease in
either neurodegeneration or behavioral
abnormalities.
The name granulin most commonly
refers to each of the 6 kDa peptides
derived by proteolysis of a precursor
designated progranulin. A 593 amino
acid secreted protein, progranulin is
cleaved by elastase (Zhu et al., 2002)
into seven peptides, each of which en-
codes a signature motif bearing 12 cys-
teine residues fully crosslinked to form
six disulfide bridges. Both progranulin
and granulin peptides possess biological
activity (Tolkatchev et al., 2008). In the
case of TLR9 activation, proteolytic pro-
cessing of granulin is required for TLR9
signaling via an effect independent of
TLR9 cleavage. Different granulins exert454 Immunity 34, April 22, 2011 ª2011 Elsevdistinct effects on cancer cells (Tol-
katchev et al., 2008), but whether one or
more specific granulin peptides mediate
the effect on TLR9 signaling was not
tested. (Note that the authors do not
distinguish between progranulin and
granulin peptides, referring generally to
‘‘granulin,’’ which could encompass
either or both the precursor and the pro-
cessed peptides.)
In advancing understanding of TLR
biology, the findings of Park et al. (2011)
naturally also raise basic questions about
the precise role of granulin in TLR9-
dependent innate immune activation.
First, does granulin show specificity in
binding to different types of nucleic
acids? Does granulin bind to single-
stranded nucleic acids in preference to
double-stranded, or to DNA in preference
to RNA? Because granulin appears to be
required specifically for TLR9 signaling,
it might be presumed that it binds only
to DNA, but this remains to be deter-ier Inc.mined. Determining the affinity of granulin
for CpG-ODN or other TLR9 ligands may
also shed light on the mechanism of
granulin function. Moreover, whether
and how the functions of granulin inter-
sect with those of other putative CpG
delivery proteins, such as HMGB proteins
(Ivanov et al., 2007), should be explored.
Another unanswered question is how
granulin, with or without bound CpG-
ODN, gains access to TLR9 in endolyso-
somes. The glycoprotein receptor sortilin,
a mediator of mannose 6-phosphate
receptor-independent delivery of soluble
lysosomal proteins to lysosomes and a
transmembrane receptor for selected
neuropeptides, was recently identified as
the major neuronal receptor for progranu-
lin (Hu et al., 2010). By means of COS-7
cells, sortilin was shown to associate
with and direct extracellularly applied pro-
granulin to lysosomes (Hu et al., 2010).
Elevated levels of progranulin exist in
brain lysates from sortilin-deficient mice,
and neurodegeneration is not observed
in these animals. It is clear that the contri-
butions of progranulin, granulin, and sorti-
lin to neuronal maintenance are complex
and probably involve both genetic and
environmental modifiers that affect
disease outcome. In macrophages, sorti-
lin traffics from the Golgi to phagosomes,
and its expression is upregulated in
response to infection of macrophages
with mycobacteria (Wa¨he et al., 2010).
Thus, an intriguing hypothesis is that sor-
tilin serves as the receptor for CpG-bound
progranulin or granulin, transporting it to
lysosomes where cleaved, signaling-
competent TLR9 is present.
Finally, the questions of whether granu-
lin is required in vivo to deliver viral or
bacterial DNA to TLR9 and whether gran-
ulin-deficient mice are therefore generally
or in certain cases hypersusceptible to
infection must be answered. The authors
showed that granulin-deficient mice
failed to induce wild-type levels of serum
TNF-a and IL-6 upon intraperitoneal injec-
tion of CpG-ODN and note that in
a previous study granulin-deficient mice
were unable to rapidly clear an infection
of Listeria monocytogenes and displayed
elevated bacterial burdens in the spleen,
liver, and brain (Yin et al., 2010).
However, these mice also experienced
an excessive and prolonged inflammatory
response to infection and exhibited age-
dependent hyperactivation of microglia
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Previewsand astrocytes, both of which suggest
a state of exaggerated inflammation that
at present is difficult to reconcile with a
requirement for granulin in innate immune
responses and particularly proinflamma-
tory cytokine production. Survival during
certain viral infections (notably infection
by mouse cytomegalovirus and other
herpesviruses) is strongly dependent on
TLR9 signaling and may be taken as
a sensitive indicator of TLR9 function.
The conclusion that granulin is a molecule
of central importance in signaling viral
invasion thus awaits further testing.
Taken together, the available data
suggest a hypothetical model in which
secreted granulin encounters and binds
to CpG-ODN, either extracellularly or
(more probably) in phagosomes (Figure 1).
Sortilin may function as the receptor for
granulin, constitutively transporting it toendolysosomes. When bound to CpG-
ODN or perhaps other TLR9 ligands,
granulin may serve to concentrate ligand
for optimal efficiency of receptor activa-
tion, as well as act as a cofactor for
TLR9 binding and activation. Future
studies will undoubtedly clarify the role
of granulin in TLR9 signaling.REFERENCES
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The molecular mechanism behind alum adjuvanticity is probably the oldest secret of immunology. In this
issue of Immunity, Kuroda et al. (2011) and Kool et al. (2011) identify NLRP3 inflammasome-independent
signaling to be crucial for the Th2 cell response induced by aluminum salts.Edward Jenner’s vaccination against
smallpox in 1789 is the first and still most
dramatic record of a successful manipula-
tion of the immune system. Early trials of
vaccine development revealed that the
efficiency of vaccines depends on the
presence of so-called adjuvants (Latin
adiuvare, to help) in conjunction with the
antigen. However, it took 200 years of
research until Charles Janeway proposed
the immunologic function of these little
helpers—to stimulate the innate immune
system. He suggested that adaptive
immunity was not raised until the innate
immune system provided clear evidence
for the presence of pathogens—or fordanger, as later extended by Polly
Matzinger. The concept of PAMPs (path-
ogen-associated molecular patterns) and
DAMPs (danger-associated molecular
patterns) triggering innate PRRs (pattern
recognition receptors) was born. The
signals triggered by PAMPs and DAMPs
strongly determine the type of adaptive
immunity, ensuring an effective clearance
of infection or appropriate inflammatory
responses to sterile tissue damage.
The most commonly used adjuvant in
humans is alum. It induces so-called
type 2 immune responses characterized
by eosinophilia and production of IL-4,
IgE, and IgG1. Although the discovery ofalum’s adjuvanticity dates back to 1926,
the underlying molecular mechanism is
still a matter of debate.
The discovery that the NLRP3 inflam-
masome senses particulates including
monosodium urate (MSU) crystals (Marti-
non et al., 2006), silica, and asbestos, as
well as alum (Dostert et al., 2008; Hornung
et al., 2008) suggested a plausiblemecha-
nism for alum’s effect as an adjuvant.
Cellular uptake of particulates leads to
reactive oxygen production and can
inflict lysosomal damage. Both of these
effects were suggested to act upstream
in the activation of NLRP3 (Dostert et al.,
2008; Hornung et al., 2008). Aluminum34, April 22, 2011 ª2011 Elsevier Inc. 455
